Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Infection

Search In Journal Title:

Abbravation: Infection

Search In Journal Abbravation:

Publisher

Springer Berlin Heidelberg

Search In Publisher:

ISSN

1439-0973

Search In ISSN:
Search In Title Of Papers:

Zur Diffusion von Cefotaxim in verschiedene Gewebe

Authors: K Schalkhäuser D Adam
Publish Date: 1980/05/01
Volume: 8, Issue: 3, Pages: S327-S329
PDF Link

Abstract

Bei 25 Patienten mit einem Prostataadenom wurden Serum und Gewebekonzentrationen im Rahmen einer perioperativen Infektionsprophylaxe nach einer i v Bolusinjektion von 20 g Cefotaxim bestimmt Die mittleren Serumkonzentrationen lagen 30 Minuten nach Injektion bei 649 µg/ml nach 60 Minuten bei 566 µg/ml nach 90 Minuten bei 452 µg/ml nach 120 Minuten bei 182 µg/ml und nach 150 Minuten bei 199 µg/ml Die korrespondierenden Konzentrationen im Prostataadenomgewebe betrugen 88 µg/g 153 µg/g 229 µg/g 43 µg/g und 27 µg/g nach 150 Minuten In ähnlicher Weise wurden in zehn Hoden von sechs Patienten die Gewebekonzentrationen bestimmt Auch hier wurde 90 Minuten nach Injektion mit 54 µg/g ein Maximum nachgewiesen In acht Nieren fanden sich als Folge unterschiedlicher Funktionsleistung bei stark voneinander abweichenden Diagnosen erheblich differierende Werte von 03–396 µg/g In Ureter Fett und Muskelgewebe fanden sich mit durchschnittlich 92–08 µg/g Konzentrationen im therapeutisch wirksamen Bereich Die insgesamt gemessenen Konzentrationen von Cefotaxim in Serum und Gewebe lassen eine erfolgversprechende Therapie bei bakteriellen Infektionen des Urogenitaltrakts mit empfindlichen Erregern erwartenWithin the framework of perioperative prophylaxis against infections serum and tissue concentrations were measured following an i v bolus injection of 20 g of cefotaxime in 25 patients with a prostatic adenoma The mean serum concentrations were 649 µg/ml 566 µg/ml 452 µg/ml 182 µg/ml and 199 µg/ml 30 60 90 120 and 150 minutes respectively following the injection The corresponding concentrations in the prostatic adenoma tissue were 88 µg/g 153 µg/g 229 µg/g 43 µg/g and 27 µg/g respectively The tissue concentrations in ten testes from six patients were measured in a similar way The maximum concentration 54 µg/g was also found to occur 90 minutes after the injection We found very different values ranging from 03 µg/g to 396 µg/g in eight kidneys as a result of greatly differing diagnoses and function Average concentrations of 92 µg/g to 08 µg/g in the ureter fatty tissue and muscle tissue were within the therapeutically effective range The cefotaxime concentrations found in serum and tissue lead us to expect successful therapy when cefotaxime is used to treat bacterial infections with sensitive pathogens in the urogenital tract


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Malassezia Species: A Rare Cause of Invasive Fungal Infections in Immunocompromised Patients
  2. Evaluation of the NanoCHIP ® Infection Control Panel test for direct detection and screening of methicillin-resistant Staphylococcus aureus (MRSA), Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria and vancomycin-resistant Enterococcus (VRE)
  3. Endocarditis caused by Streptococcus canis : an emerging zoonosis?
  4. Increasing Occurrence of Multidrug-Resistance in Acinetobacter baumannii Isolates From Four German University Hospitals, 2002–2006
  5. Antineutrophil cytoplasmic antibody-associated vasculitis associated with Epstein–Barr virus infection: a case report and review of the literature
  6. Validation of a multiplex reverse transcriptase PCR ELISA for the detection of 19 respiratory tract pathogens
  7. Interferon-γ releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants
  8. Complicated Community-Acquired Soft Tissue Infection by MRSA from Porcine Origin
  9. Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation
  10. Reasons for not starting antiretroviral therapy in HIV-1-infected individuals: a changing landscape
  11. Serum Citrate Levels, Haptoglobin Haplotypes and Transferrin Receptor (CD71) in Patients With HIV-1 Infection
  12. Immune-Mediated Severe Hemolytic Crisis with a Hemoglobin Level of 1.6 g/dl Caused by Anti-Piperacillin Antibodies in a Patient with Cystic Fibrosis
  13. Combination of Quinupristin/Dalfopristin and Glycopeptide in Severe Methicillin-Resistant Staphylococcal Infections Failing Previous Glycopeptide Regimens
  14. Challenging cases discussed by experts: retinal vasculitis following coinfection with HIV and syphilis
  15. Extended-spectrum β-lactamase-producing Escherichia coli strains in the feces of carriers contribute substantially to urinary tract infections in these patients
  16. Relevance of intracranial hypertension control in the management of Cryptococcus neoformans meningitis related to AIDS
  17. A case of postmalaria neurological syndrome in Japan
  18. Produktion und Reinigung des thermolabilen Escherichia coli-Enterotoxins
  19. Economic burden of Clostridium difficile associated diarrhoea: a cost-of-illness study from a German tertiary care hospital
  20. Current Antifungal Agents for Treatment of Central Nervous System Infections
  21. Experience with daptomycin daily dosing in ICU patients undergoing continuous renal replacement therapy
  22. Failure of Current Antibiotic First-Line Regimens and Mortality in Hospitalized Patients with Spontaneous Bacterial Peritonitis
  23. Das Buckley-Syndrom: Rezidivierende, schwere Staphylokokken-infektionen, Ekzem und Hyperimmunglobulinämie E
  24. Diagnosis of prosthetic joint infections using UMD-Universal Kit and the automated multiplex-PCR Unyvero i60 ITI ® cartridge system: a pilot study
  25. Why is antimicrobial de-escalation under-prescribed for urinary tract infections?
  26. Is aciclovir prophylaxis necessary after bone marrow transplantation?
  27. Rare Fungal Infections in Children: An Updated Review of the Literature
  28. Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci
  29. Diagnosis of tubercular uveitis by quantitative polymerase chain reaction
  30. New developments in the antifungal susceptibility testing of Candida
  31. The in vitro activity of ampicillin, amoxicillin, cephalexin, nitrofurantoin, sulphadiazine and trimethoprim against Streptococcus agalactiae isolated from urinary and other infections
  32. Reply: Is it really Aeromonas hydrophila ?
  33. Comparison of the clinical characteristics of Mycobacterium tuberculosis and nontuberculous mycobacteria patients with joint involvement
  34. Detection of Early Liver Fibrosis in Patients with Intestinal Schistosomiasis: Sonographic and Histologic Findings in Schistosoma mansoni Infection
  35. Hepatitis E virus in the countries of the Middle East and North Africa region: an awareness of an infectious threat to blood safety
  36. Asepsis und Antisepsis bei der Behandlung des Brandverletzten
  37. Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli : an analysis of the disease burden in a large cohort
  38. Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review

Search Result: